doi: 10.3389/fneph.2024.1390783 Received 23 February 2024 Accepted 15 May 2024 Published 04 June 2024 Volume 4 - 2024 Edited by Duvuru Geetha, Johns Hopkins Medicine, United States Reviewed by Dhanunjay Mukhi, University of Pennsylvania, United States Enrique Morales, CSUR complex glomerular pathology, Spain Updates Copyright 2024 Gholizadeh Ghozloujeh, Singh, Jhaveri, Shah, Lerma, Abdipour and Norouzi
The expectation of responsible, ethical utilization of this information for legitimate investigative and scholarly objectives is paramount
Changes in body image, shifts in how others treat you, and physical experience of losing weight quickly can all feel destabilizing
Retatrutide's triple receptor agonism shows great potential to address weight loss more effectively than other treatments, as suggested by early comparisons of Retatrutide versus tirzepatide
Amazing results Retatrutide has been a game changer for my research